Zimmer Biomet Holdings Inc (ZBH)
107.25
-0.05
(-0.05%)
USD |
NYSE |
Dec 26, 16:00
108.15
+0.90
(+0.84%)
Pre-Market: 06:37
Zimmer Biomet Holdings Research and Development Expense (Quarterly): 111.60M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
ResMed Inc | 79.52M |
Stryker Corp | 377.00M |
Haemonetics Corp | 16.53M |
Globus Medical Inc | 35.38M |
Nutriband Inc | 0.8808M |